These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

772 related items for PubMed ID: 18635531

  • 21. Prevalence and cardiovascular disease risk of the metabolic syndrome using National Cholesterol Education Program and International Diabetes Federation definitions in the Korean population.
    Choi KM, Kim SM, Kim YE, Choi DS, Baik SH, Lee J, International Diabetes Federation.
    Metabolism; 2007 Apr; 56(4):552-8. PubMed ID: 17379016
    [Abstract] [Full Text] [Related]

  • 22. Different definitions of the metabolic syndrome and risk of first-ever acute ischaemic non-embolic stroke in elderly subjects.
    Milionis HJ, Kostapanos MS, Liberopoulos EN, Goudevenos J, Athyros VG, Mikhailidis DP, Elisaf MS.
    Int J Clin Pract; 2007 Apr; 61(4):545-51. PubMed ID: 17394429
    [Abstract] [Full Text] [Related]

  • 23. Frequency of metabolic syndrome among hemodialysis patients according to NCEP-ATP III and IDF definitions.
    Ucar E, Huzmeli C, Guven O, Savas N, Gullu M, Asilyoruk S, Kuvandik C, Temizkan A, Kuvandik G.
    Ren Fail; 2009 Apr; 31(3):221-8. PubMed ID: 19288328
    [Abstract] [Full Text] [Related]

  • 24. Age-specific prevalence of the metabolic syndrome defined by the International Diabetes Federation and the National Cholesterol Education Program: the Norwegian HUNT 2 study.
    Hildrum B, Mykletun A, Hole T, Midthjell K, Dahl AA.
    BMC Public Health; 2007 Aug 29; 7():220. PubMed ID: 17727697
    [Abstract] [Full Text] [Related]

  • 25. The metabolic syndrome predicts cardiovascular mortality: a 13-year follow-up study in elderly non-diabetic Finns.
    Wang J, Ruotsalainen S, Moilanen L, Lepistö P, Laakso M, Kuusisto J.
    Eur Heart J; 2007 Apr 29; 28(7):857-64. PubMed ID: 17303589
    [Abstract] [Full Text] [Related]

  • 26. National Cholesterol Education Program versus World Health Organization metabolic syndrome in relation to all-cause and cardiovascular mortality in the San Antonio Heart Study.
    Hunt KJ, Resendez RG, Williams K, Haffner SM, Stern MP, San Antonio Heart Study.
    Circulation; 2004 Sep 07; 110(10):1251-7. PubMed ID: 15326061
    [Abstract] [Full Text] [Related]

  • 27. Metabolic characteristics of women with polycystic ovaries and oligo-amenorrhoea but normal androgen levels: implications for the management of polycystic ovary syndrome.
    Barber TM, Wass JA, McCarthy MI, Franks S.
    Clin Endocrinol (Oxf); 2007 Apr 07; 66(4):513-7. PubMed ID: 17371468
    [Abstract] [Full Text] [Related]

  • 28. Differences in traditional and emerging cardiovascular risk factors of subjects discordantly classified by metabolic syndrome definitions of the International Diabetes Federation and the National Cholesterol Education Program.
    Boronat M, Saavedra P, Varillas VF, Wagner AM, López-Plasencia Y, Alberiche MP, Nóvoa FJ.
    Nutr Metab Cardiovasc Dis; 2009 Jul 07; 19(6):417-22. PubMed ID: 18819785
    [Abstract] [Full Text] [Related]

  • 29. The new definition of metabolic syndrome by the international diabetes federation is less likely to identify metabolically abnormal but non-obese individuals than the definition by the revised national cholesterol education program: the Korea NHANES study.
    Yoon YS, Lee ES, Park C, Lee S, Oh SW.
    Int J Obes (Lond); 2007 Mar 07; 31(3):528-34. PubMed ID: 16865099
    [Abstract] [Full Text] [Related]

  • 30. The implications of anthropometric, inflammatory and glycaemic control indices in the epidemiology of the metabolic syndrome given by different definitions: a classification analysis.
    Panagiotakos DB, Pitsavos C, Das UN, Skoumas Y, Stefanadis C.
    Diabetes Obes Metab; 2007 Sep 07; 9(5):660-8. PubMed ID: 17697058
    [Abstract] [Full Text] [Related]

  • 31. Prognostic impact of metabolic syndrome by different definitions in a population with high prevalence of obesity and diabetes: the Strong Heart Study.
    de Simone G, Devereux RB, Chinali M, Best LG, Lee ET, Galloway JM, Resnick HE, Strong Heart Study Investigators.
    Diabetes Care; 2007 Jul 07; 30(7):1851-6. PubMed ID: 17440172
    [Abstract] [Full Text] [Related]

  • 32. Comparison of definitions of the metabolic syndrome in adult Asian Indians.
    Wasir JS, Misra A, Vikram NK, Pandey RM, Gupta R.
    J Assoc Physicians India; 2008 Mar 07; 56():158-64. PubMed ID: 18697631
    [Abstract] [Full Text] [Related]

  • 33. Prevalence of metabolic syndrome and its relationship to white blood cell count in a population of Thai men and women receiving routine health examinations.
    Lohsoonthorn V, Dhanamun B, Williams MA.
    Am J Hypertens; 2006 Apr 07; 19(4):339-45. PubMed ID: 16580566
    [Abstract] [Full Text] [Related]

  • 34. Risk of metabolic complications in the new PCOS phenotypes based on the Rotterdam criteria.
    Shroff R, Syrop CH, Davis W, Van Voorhis BJ, Dokras A.
    Fertil Steril; 2007 Nov 07; 88(5):1389-95. PubMed ID: 17462641
    [Abstract] [Full Text] [Related]

  • 35. Metabolic syndrome in young Czech women with polycystic ovary syndrome.
    Vrbíková J, Vondra K, Cibula D, Dvoráková K, Stanická S, Srámková D, Sindelka G, Hill M, Bendlová B, Skrha J.
    Hum Reprod; 2005 Dec 07; 20(12):3328-32. PubMed ID: 16085666
    [Abstract] [Full Text] [Related]

  • 36. Is a unified definition of metabolic syndrome needed? Comparison of three definitions of metabolic syndrome in 60-year-old men and women.
    Carlsson AC, Wändell PE, Halldin M, de Faire U, Hellénius ML.
    Metab Syndr Relat Disord; 2009 Jun 07; 7(3):231-41. PubMed ID: 19284315
    [Abstract] [Full Text] [Related]

  • 37. Comparison of different definitions of the metabolic syndrome.
    Sandhofer A, Iglseder B, Paulweber B, Ebenbichler CF, Patsch JR.
    Eur J Clin Invest; 2007 Feb 07; 37(2):109-16. PubMed ID: 17217376
    [Abstract] [Full Text] [Related]

  • 38. Lipid accumulation product as a marker of cardiometabolic susceptibility in women with different phenotypes of polycystic ovary syndrome.
    Božić-Antić I, Ilić D, Bjekić-Macut J, Bogavac T, Vojnović-Milutinović D, Kastratovic-Kotlica B, Milić N, Stanojlović O, Andrić Z, Macut D.
    Eur J Endocrinol; 2016 Dec 07; 175(6):551-560. PubMed ID: 27634940
    [Abstract] [Full Text] [Related]

  • 39. Metabolic syndrome in Mediterranean women with polycystic ovary syndrome: when and how to predict its onset.
    Espinós-Gómez JJ, Rodriguez-Espinosa J, Ordóñez-Llanos J, Calaf-Alsina J.
    Gynecol Endocrinol; 2012 Apr 07; 28(4):264-8. PubMed ID: 21962027
    [Abstract] [Full Text] [Related]

  • 40. Diagnosing metabolic syndrome in type 2 diabetes: does it matter?
    Song SH, Hardisty CA.
    QJM; 2008 Jun 07; 101(6):487-91. PubMed ID: 18353792
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 39.